Singapore biotech startup Gero raises $2.2m in Series A round

The Gero team (from left): Konstantin Avchaciov, Peter Fedichev and Olga Burmistrova.

Biotech startup Gero has raised $2.2 million in a Series A round led by Belarus-based Bulba Ventures, the Singapore-based startup said in a press release on Tuesday.

The financing brought the total capital raised by the firm to more than $7.5 million, the company said. Gero had raised seed funding in May 2019, according to Crunchbase data.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter